Evofosfomide potentiates the efficacy of a novel anti-PD-L1/PD-L2 monoclonal antibody against immune excluded tumors

Yervoy (ipilimumab) - Ono Pharma, BMS

Zymafos (palifosfamide) - Alaunos Therap

IMGS-001 - ImmunoGenesis

evofosfamide (IMGS-101) - Molecular Templates, ImmunoGenesis

https://jitc.bmj.com/content/11/Suppl_1/A953

Ahmad Salameh1; Paul Blezinger1; Christine Gagliardi1; Matt Hemberger1; James Barlow1; Michael Curran2; Federica Pericle1

Sep 27, 2023